NYSE - Delayed Quote USD

Neuberger Berman High Yield Strategies Fund Inc. (NHS)

7.95 +0.02 (+0.25%)
At close: April 25 at 4:00 PM EDT
7.95 0.00 (0.00%)
After hours: April 25 at 4:04 PM EDT
Loading Chart for NHS
DELL
  • Previous Close 7.93
  • Open 7.92
  • Bid --
  • Ask --
  • Day's Range 7.91 - 7.95
  • 52 Week Range 6.95 - 9.13
  • Volume 78,953
  • Avg. Volume 96,461
  • Market Cap (intraday) 206.164M
  • Beta (5Y Monthly) 0.97
  • PE Ratio (TTM) 49.69
  • EPS (TTM) 0.16
  • Earnings Date --
  • Forward Dividend & Yield 1.09 (13.66%)
  • Ex-Dividend Date Apr 12, 2024
  • 1y Target Est --

Neuberger Berman High Yield Strategies Fund Inc. is a closed-ended fixed income mutual fund launched by Neuberger Berman LLC. The fund is managed by Neuberger Berman Investment Advisers LLC. It invests in fixed income markets across the globe. The fund typically invests in high yield debt securities of various sectors, such as auto parts and equipment, airlines, automotive, electronics, health services, packaging, telecom-integrated/services, gaming, and gas distribution. It was formerly known as Neuberger Berman High Yield Strategies Fund. Neuberger Berman High Yield Strategies Fund Inc. was formed on July 28, 2003 and is domiciled in the United States.

www.nb.com/Pages/Public/en-us/Products/high-yield-strategies-fund.aspx

--

Full Time Employees

October 31

Fiscal Year Ends

Recent News: NHS

Performance Overview: NHS

Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

NHS
7.75%
S&P 500
5.84%

1-Year Return

NHS
0.76%
S&P 500
22.03%

3-Year Return

NHS
11.04%
S&P 500
20.77%

5-Year Return

NHS
15.77%
S&P 500
72.46%

Compare To: NHS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NHS

Valuation Measures

Annual
As of 4/25/2024
  • Market Cap

    206.16M

  • Enterprise Value

    --

  • Trailing P/E

    49.69

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    21.16

  • Price/Book (mrq)

    1.06

  • Enterprise Value/Revenue

    23.69

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    16.63%

  • Return on Assets (ttm)

    4.13%

  • Return on Equity (ttm)

    2.05%

  • Revenue (ttm)

    22.35M

  • Net Income Avi to Common (ttm)

    3.72M

  • Diluted EPS (ttm)

    0.16

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    54.48%

  • Levered Free Cash Flow (ttm)

    3.1M

Company Insights: NHS

People Also Watch